You have 9 free searches left this month | for more free features.

Lung Tumor

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer, Wedge Resection, Ground-glass Opacity Trial in Shanghai (Wedge resection)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Wedge resection
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 25, 2023

Lung Cancer, Lung Metastases Trial in Orlando (VGT-309)

Recruiting
  • Lung Cancer
  • Lung Metastases
  • Orlando, Florida
    Orlando Health Cancer Institute
Nov 22, 2023

Circulating Tumor Cells (CTC) in Lung Cancer

Recruiting
  • Lung Neoplasms
  • Blood draw
  • Indianapolis, Indiana
  • +1 more
Sep 23, 2022

Circulating Tumor DNA in Surgical Patients With Lung Cancer

Active, not recruiting
  • Lung Cancer
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 12, 2022

    Pathological Tumor and Lymph Node Responses After Neoadjuvant

    Completed
    • Non Small Cell Lung Cancer
    • +3 more
    • Timing of drug administration
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Tumor treating fields(EFE-P100)
    • Docetaxel injection
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Dec 21, 2022

    Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

    Recruiting
    • Lung Cancer
      • Shanghai, China
        Shanghai Chest Hospital
      Jul 20, 2023

      Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

      Recruiting
      • Small Cell Lung Cancer
      • Neuroendocrine Carcinoma
      • Chiba, Japan
      • +1 more
      Jan 16, 2023

      Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

      Recruiting
      • Lung Adenocarcinoma
      • Shijiazhuang, Hebei, China
        The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
      Sep 24, 2023

      NSCLC Trial in Shanghai

      Not yet recruiting
      • Non-small Cell Lung Cancer
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Jul 20, 2023

        MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

        Not yet recruiting
        • Lung Neoplasms
        • +2 more
        • Tumor samples
        • Bordeaux, France
          CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
        Aug 28, 2023

        Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

        Not yet recruiting
        • Metastatic Breast Cancer
        • +2 more
        • Patritumab deruxtecan
        • (no location specified)
        May 9, 2023

        Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)

        Not yet recruiting
        • Adenocarcinoma of Lung
        • NovoTTF-200T System
        • Basking Ridge, New Jersey
        • +6 more
        Mar 3, 2023

        Blood, Urine, and Bone Marrow

        Recruiting
        • Non Small Cell Lung Cancer
        • +5 more
        • Test for circulating tumor cells, DNA alterations
        • Columbia, Missouri
          Harry S Truman Veterans Memorial Hospital
        Oct 31, 2022

        Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

        Recruiting
        • Advanced Solid Tumor
        • Refractory Tumor
        • Radiotherapy
        • +4 more
        • Suzhou, China
          The Second Affiliated Hospital of SchoowUniversity
        Sep 14, 2023

        Lung Tumor, Thoracoscopic Surgery Trial in Taoyuan (localization)

        Recruiting
        • Lung Tumor
        • Thoracoscopic Surgery
        • localization
        • Taoyuan, Taiwan
          Chang Gung Memorial Hospital
        Jul 23, 2021

        Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • +4 more
        • (no location specified)
        Oct 23, 2023

        Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

        Not yet recruiting
        • Lung Non-Small Cell Carcinoma
        • +3 more
        • Pulmonary Artery-First Surgical Technique
        • Biospecimen Collection
        • (no location specified)
        Aug 15, 2022

        Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

        Not yet recruiting
        • Advanced Solid Tumor
        • +7 more
        • WM-A1-3389
        • Pembrolizumab
        • Seoul, Seocho-gu, Korea, Republic of
        • +1 more
        May 14, 2023

        Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

        Not yet recruiting
        • Carcinoid Tumor Lung
        • +2 more
        • 212-Lead Pentixather
        • 203-Lead Pentixather SPECT/CT
        • Iowa City, Iowa
          The University of Iowa Theranostics Center
        Sep 23, 2022

        Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

        Recruiting
        • Advanced Lung Carcinoid Tumor
        • +11 more
        • Boston, Massachusetts
        • +1 more
        Jul 19, 2022

        Molecular Signature From Tumor to Lymph Nodes

        Recruiting
        • Lung Cancer
        • +4 more
          • Bordeaux, France
          • +11 more
          Jan 6, 2023

          Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

          Not yet recruiting
          • Lung Neoplasm
          • +2 more
          • Tumor samples
          • Bordeaux, France
            CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
          Aug 28, 2023

          Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

          Not yet recruiting
          • Small Cell Lung Cancer Extensive Stage
          • Jinan, China
          • +2 more
          Sep 10, 2023

          Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

          Not yet recruiting
          • Solid Tumor
          • +4 more
          • (no location specified)
          Feb 21, 2023